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Abstract
Background:  Nested nucleic acid amplification tests are often thought too sensitive or prone to
generatingfalse positive results for routine use. The current study investigated the specificity and
clinicalutility of a routine multiplex nested assay for mucosal herpetic infections.
Methods:  Ninety patients, categorised into those clinically diagnosed to (a) have and (b) not
haveherpetic infection, were enrolled. Swabs from oral and ano-genital sites were assayed by
thenested assay and culture and the results assessed against clinical evaluation for
diagnosingherpetic infections; cell content was also recorded.
Results:  Twenty-six and 64 patients were thought to (a) have and (b) not have mucosal
herpeticinfection. Taking the clinical evaluation as indicating the presence of herpetic infection,
thenested polymerase chain reaction and culture had respective sensitivities of 19/26 (73%) and12/
26 (46%) (Χ 2 p = 0.02). There was no significant difference in specificities between nPCR62/64
(97%) and culture 63/64 (98%) (Χ 2 p = 1.0). Cell content was important for viraldetection by nPCR
(Χ 2 p = 0.07) but not culture. Nesting was found necessary for sensitivity anddid not reduce
specificity. Assay under-performance appeared related to sub-optimal cellcontent (20%) but may
have reflected clinical over-diagnosis. The results suggest the need forvalidating specimen cell
quality.
Conclusions:  This study questions the value of routine laboratory confirmation of mucosal
herpetic infection. The adoption of a more discriminatory usage of laboratory diagnostic facilities
for genital herpetic infection, taking account of cell content, and restricting it to those cases where
it actually affects patient management, may be warranted.
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Background
Herpes simplex virus types 1 and 2 (HSV-1 and HSV-2)
infections are among the commonest clinically encoun-
tered in medical practice and worldwide are the main
causes of oral and genital ulceration [1–4]. HSV-2 is nor-
mally linked to genital ulceration but increasingly HSV-1
is also encountered and in Northern Ireland has become
the predominant genital type recovered from women [5].
It is recognised that genital infections with either virus
present with painful muco-cutaneous lesions in 95% of
primary cases, and in 84% with non-primary episodes;
constitutional upset accompanies 79% and 43% of pri-
mary and non-primary episodes respectively [6]. Al-
though culture remains the gold standard for the direct
diagnosis of HSV associated mucosal ulceration [7], in-
creasingly HSV specific nucleic acid amplification test
(NAT) assays are being recognised to improve test sensi-
tivity [2,8,9]. Real-time assays are also becoming availa-
ble [10–12] but are currently beyond the price range of
many laboratories. We have previously reported a multi-
plex nested polymerase chain reaction (nPCR) assay for
HSV detection, with significantly improved sensitivity
when compared to standard virus culture [13]. However
in routine practice there are two main concerns sur-
rounding the use of a nested NAT format. First there is
concern that the high sensitivity will result in the detec-
tion of clinically non-significant levels of infection, spe-
cifically asymptomatic shedding in the case of HSV.
Secondly the assays are thought susceptible to generat-
ing false positive results [7,14–16] and therefore will
have an unacceptable level of specificity for routine prac-
tice. For these reasons we felt it necessary to validate the
clinical performance of the multiplex nPCR assay we
routinely use for HSV diagnosis. This study utilised the
predictive value of clinical evaluation for diagnosing
muco-cutaneous HSV infection by experienced medical
personnel and was based in a genitourinary medicine
clinic.
Methods
Patients
Over a 3 month period 90 patients who presented to the
Department of Genitourinary Medicine, Royal Victoria
Hospital, Belfast, were investigated for evidence of HSV
infection. In addition to their routine assessment they
were also selected for additional clinical categorisation
by the attending consultants into those patients thought
to (a) have, and (b) not have, clinical evidence in keeping
with herpetic infection. Following a detailed history and
examination patients with suspected herpetic infection
were recorded as having : (i) primary HSV; (ii) first clin-
ical episode of non-primary HSV; (iii) recurrent HSV.
Those thought not to have herpetic infection involved pa-
tients with ulcerative or inflammatory lesions catego-
rised on clinical examination as non-specific in nature.
Specimens
Swabs were taken from appropriate oral (2) and ano-
genital sites (88) including penile, vulval, vaginal and
anal specimens. The swabs were sent to the laboratory in
2 ml of viral transport medium consisting of phosphate
buffered saline (PBS) pH 7.1, bovine serum albumin 7.5
µg/ml, penicillin G sodium 10 units/ml, streptomycin
sulphate 10 µg/ml and amphotericin B 0.25 µg/ml. Each
specimen was vortexed for 15 seconds on receipt in the
laboratory to resuspend the cellular content, but other-
wise received no further pre-treatment. A 50 µl volume
was removed for virus culture and multiplex nPCR. A 1.5
ml volume of the remainder of the specimen was centri-
fuged in a screw-capped polypropylene tube (Sarstedt) at
15000 g for 10 minutes to assess the specimen cell con-
tent. Cell pellets of less than 2 mm in diameter were re-
garded as sub-optimal.
Virus culture
Virus culture was undertaken as reported previously
[17]. Suspensions of 4 cell lines consisting of primary
rhesus monkey kidney (CPHL, Porton Down, England),
E6-vero (ATCC CRL1586), RD (ATCC CCL136) and HEp-
2 (ATCC CCL23) were used. Four wells of 96 well U-bot-
tomed tissue culture plates (Becton Dickinson, Oxford,
England) were each inoculated with 10 µl of the speci-
men; all of the wells contained 90 µl of serum free Eagle's
minimum essential medium (MEM) (Bio-Whittaker UK
Ltd, Wokingham, England). Log dilutions from each in-
oculated well were made to 3 adjacent wells (in a column
of 4) by the sequential transfer of 10 µl volumes. Each of
the 4 cell suspensions (25 µl), in MEM with 10% fetal calf
serum (Life Technologies, Paisley, Scotland, UK), was
added to its corresponding column. The plates were in-
cubated in a sealed box in a 5% CO2 atmosphere at 37°C
for 7 days and read daily for the presence of cytopathic
effect (CPE). Cells showing CPE were harvested and
screened by the Syva MicroTrak HSV-1 and HSV-2 cul-
ture confirmation system (Behring, Milton Keynes, Eng-
land).
Table 1: PCR Cycling Conditions
Cycle Conditions First Round1 Second Round1
Denaturation 94°C – 10 s 94°C – 10 s
Annealing 58°C – 10 s 67°C – 10 s
Extension 72°C – 30 s 72°C – 30 s
Number of Cycles 35 25
1The thermal cycler was held at 94°C for 3 min before cycling began 
to facilitate the transfer of specimens, held on ice, for a hot start pro-
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Multiplex HSV-1 and HSV-2 nPCR
This was undertaken as previously described [13] using
primers recognising the HSV-1 gpD gene and the HSV-2
gpG gene in a multiplex nPCR; HSV-1 and HSV-2 outer
products were 221 and 184 base pairs (bp) while the in-
ner products were 138 and 101 bp respectively. The assay
has respective sensitivities of 0.01 and 0.1 TCID50 for
HSV-1 and HSV-2. Briefly, hot-start was commenced in
a Perkin Elmer GeneAmp 2400 thermal cycler with the
cycling conditions as shown in Table 1. Specimens (10 µl)
were added to 40 µl of mix and subjected to 35 first
round cycles. One microlitre of product was transferred
to 49 µl of second round mix for 25 second round cycles.
A positive HSV control and a distilled water negative
control were included in each run. First and second
round products were visualised together on ethidium
bromide-stained 2% agarose gels and photographed (Po-
laroid). Appropriately sized bands present on second
round only, or present on both first and second rounds,
were recorded as positive and strong positive respective-
ly. All positive specimens were re-tested.
Statistical analysis
The clinical categorisation data for the patients was cor-
related with the results obtained by viral culture and
nPCR. Difference in sensitivity and specificity between
culture and nPCR and also the analysis of the impact of
cell content on virus recovery in patients with clinical
genital herpes infection versus those without evidence of
HSV infection was determined by a two-tailed Chi-
square (Χ 2) test. Differences between herpes virus recov-
ery by culture and nPCR in relation to the specimen cell
content was compared using the Fisher exact test.
Results
Patients and specimens
Twenty-six of the 90 patients seen were thought on clin-
ical grounds to have mucosal herpes while the remaining
64 were assessed as having non-specific lesions incon-
sistent with herpetic involvement. All patient specimens
sent to the laboratory were received within 24 hours. Of
the specimens received, 18/90 (20%) were found to be
sub-optimal on the basis of a pellet size less than 2 mm
in diameter after centrifugation.
Virus culture and nPCR
Taking the clinical diagnosis as the indicator of HSV in-
fection, nPCR and culture had respective sensitivities of
19/26 (73%) and 12/26 (46%) (Χ 2 p = 0.02) and specifi-
cities of 62/64 (97%) and 63/64 (98%) (Χ 2 p = 1.0); all
PCR positive specimens were repeatedly reactive. There
was a similar percentage of specimens with sub-optimal
cell content from patients with herpes infection diag-
nosed on clinical grounds compared to those without ob-
vious evidence of HSV infection (4/26 (15%) versus 14/
64 (22%) (Χ 2 p = 0.48)). The cell content improved the
identification of virus by nPCR in those patients with
clinical herpetic infection (1/4 with poor cell content ver-
sus 17/22 with good cell content (Χ 2 p = 0.07)) while this
was not so for results obtained by viral culture (1/4 with
poor cell content versus 11/22 with good cell content (Χ 2
p = 0.59). The virus type by nPCR concurred with that
isolated in all cases. There were 2 and 1 cases diagnosed
by nPCR and culture respectively where the clinical diag-
nosis was not regarded as suggestive of HSV infection.
HSV-2 was detected: (a) by nPCR and culture in a patient
diagnosed with chronic candidiasis and (b) by nPCR
alone in a second patient, diagnosed with an aphthous
ulcer.
Discussion
The potential for amplicon contamination associated
with NAT assay use is well recognised and makes manda-
tory the use of (a) separate, designated work stations and
(b) a uni-directional work-flow from specimen prepara-
tion to amplified product analysis; this model of opera-
tion is standard in our laboratory . The increased
sensitivity and additional amplification step of nested
NAT assays is thought especially to be coupled with com-
promised specificity resulting from false positive results.
Because of this they are commonly regarded as unsuita-
ble for use in routine practice. This study was designed to
address this belief. Its design relied on the predictive val-
ue of clinical judgement for diagnosing mucosal herpetic
infection as the basis for estimating test specificity. In
particular the setting of the study in a department of gen-
itourinary medicine further strengthened the acumen of
clinical diagnosis. False positive results, detection of
asymptomatic shedding and clinical under-estimation of
herpetic infection would be reflected by compromised
assay specificity. The results confirmed high assay spe-
cificities with no significant difference between the nest-
ed NAT format and the current gold standard of virus
culture (Χ 2 p = 0.3). This provided convincing evidence
of both (a) the appropriateness of the nested NAT assay's
detection threshold for mucosal herpes infection and (b)
its usefulness in a routine setting.
Two laboratory confirmed cases, clinically evaluated to
lack evidence of herpetic infection, implied inappropri-
ate detection in one, and/or a false positive result in the
other; both cases involved HSV-2 detection. The first,
treated as a chronic candidasis infection, was positive by
both nPCR and culture (and also by immunofluores-
cence, though not part of this study). The second, treated
clinically as a non-herpetic aphthous ulcer, was positive
by nPCR alone. The 3 positive assays in the first case
would indicate the infection was genuine, possibly ob-
scured clinically by the presenting candidiasis . However
it could also represent asymptomatic shedding of virusBMC Infectious Diseases 2001, 1:11 http://www.biomedcentral.com/1471-2334/1/11
or atypical clinical presentation. In the second case the
nPCR assay recorded a strong positive HSV-2 signal
from the submitted specimen. Because the specimen was
not extracted but reactive after direct addition into the
first round reaction mix, we believe the likelihood of con-
tamination at this step to be minimal. Also the detection
was repeatable. In routine practice when clinical details
and laboratory findings conflict we test a further speci-
men; a standard turn-around time of ≤  24 hours for all
NAT assays in our laboratory allows this approach.
While confirming the expected improvement in sensitiv-
ity ((19/26 (73%) and 12/26 (46%) (Χ 2 p = 0.02)) of
nPCR, the overall poor performance of both the nPCR
and virus culture assays was unexpected. Since both have
performed optimally in external quality assessment pro-
grams (NEQAS, run by the Public Health Laboratory
Service for viral culture and the QCCA program run by
the European Society for Clinical Virology for HSV PCR)
we do not believe assay under-performance to be respon-
sible. Additionally we have never encountered a speci-
men that yielded a virus on culture that was PCR
negative, even without specimen extraction, indicating
that PCR inhibitors are not involved or are very uncom-
mon. A number of factors may have accounted for the
observation. We believe the major impact was associated
with specimens containing a sub-optimal cell content
(20%). Our results indicated this had a bearing on the
level of virus detected, especially by culture. Also it could
be suggested that not pre-extracting the specimens may
have compromised the nPCR assay. However from inter-
nal audit findings (unpublished) we have shown that
pre-extraction does not increase the yield of HSV recov-
ery from genital specimens with this assay. Finally, mis-
diagnosed herpetic infections may also have factored
into the low yield. Against a recent report of syphilis in-
creases [18] the potential for its misdiagnosis as atypical
herpetic infection [19] is very real, underlying the impor-
tance of using tests of high sensitivity, which clearly do
not include culture.
The results of this study indicated that a nested format of
NAT assay was not only suitable for routine application
but essential for achieving adequate sensitivity levels.
The sensitivity levels of nested NAT formats therefore
warrant their consideration by laboratories offering di-
agnostic facilities for herpetic infection. The other major
advantage of this multiplex nested format is that it re-
moves the necessity for pre-test extraction and automat-
ically types the virus identified. Nesting with these
primers has proven sufficient to overcome any inhibitors
which would be expected in specimens of this nature and
to date we have been unable through audit to provide ev-
idence to support the need for specimen extraction,
which for our other routine NAT assays is essential.
However our results would suggest the need for validat-
ing specimen quality. For specimens sent in lysis buffer
this is likely to require the quantitative ability associated
with Real-time assays while for those in viral transport
medium assessing cell content would suffice. While
Real-time assays are becoming available they are expen-
sive and are currently outside the cost range of many
routine virology laboratories. In the meantime retention
of culture for HSV diagnosis, or its replacement with
standard PCR, will result in missed laboratory diagnosis
and a compensatory over-reliance on uncorroborated
clinical judgement.
More fundamentally these results bring into question the
need for the laboratory confirmation of genital herpetic
infection. Currently the laboratory confirmation and typ-
ing of herpetic involvement in genital herpes is recom-
mended practice [20]. Our results indicate that
laboratory results are adding little to clinical judgement
in the majority of cases. They are at best typing the virus
in approximately 70% of the cases investigated. While it
is suggested that the virus type affects patient manage-
ment through tailored counselling, it is questionable
whether in the majority of cases the advice given will al-
ter. By having a blanket approach to the use of laboratory
methods for confirming herpetic infection, which consti-
tutes a major component of most virus laboratories
workload, scarce resources are being diverted from areas
where they could be more useful, e.g. wider access to mu-
tational analysis. We believe it is time to have a more dis-
criminatory approach to the laboratory diagnosis of
genital herpetic infection, restricting it to those cases
where it actually affects patient management, and doing
it well.
Conclusions
A nested amplification format for the laboratory diagno-
sis of mucosal herpetic infection was found to be neces-
sary for adequate test sensitivity while not sacrificing test
specificity. The unexpected poor sensitivity of both as-
says with comparison to clinical evaluation was probably
related to the number of specimens with sub-optimal cell
content (20%), but over-diagnosis of herpetic infection
could have contributed to the findings. The results clear-
ly suggest the need for validating specimen quality, ei-
ther through cell count for specimens in viral transport
medium or Real-time target quantification for those in
lysis buffer. The results question the value of routine lab-
oratory confirmation of mucosal herpetic infection. They
suggest the need for a more discriminatory approach,
taking account of the cell content, and restricting it to
those cases where it actually affects patient manage-
ment.BMC Infectious Diseases 2001, 1:11 http://www.biomedcentral.com/1471-2334/1/11
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